HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

Hematopoietic stem cell transplantation (HSCT) still remains the only definitive cure currently available for patients with thalassemia and sickle cell anemia.  Results of transplant in thalassemia  and in sickle cell anemia  have steadily improved over the last two decades due to improvements in pr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
Format:	Artigo
Idioma:	Inglês
Publicat:	PAGEPress Publications 2009-12-01
Col·lecció:	Mediterranean Journal of Hematology and Infectious Diseases
Matèries:	Hematopoietic Stem Cell Transplantation, Thalassemia , Sickle Cell Disease, Developping Countries
Accés en línia:	http://www.mjhid.org/index.php/mjhid/article/view/114
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!